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Prospective evaluation of haemoglobin oxygen saturation at
rest and after exercise in paediatric sickle cell disease patients
A lowering of the haemoglobin oxygen saturation as deter-
mined by pulse oximetry is common in patients with sickle cell
disease at steady state despite the lack of overt evidence of
pulmonary dysfunction or intrinsic lung disease (Rackoff et al,
1993; Homi et al, 1997; Setty et al, 2003; Quinn & Ahmad,
2005). Decreased affinity of haemoglobin S for oxygen (Seakins
et al, 1973; Ueda et al, 1979) and increased erythrocyte 2,3-
bisphosphoglycerate (Milner, 1974) may partially, but proba-
bly not fully, explain decreased oxygen saturation in sickle cell
disease given the wide range of saturations in patients. Several
groups have reported the association of low haemoglobin
oxygen saturation in sickle cell disease with elevated serum
lactate dehydrogenase, severity of anaemia and/or reticulo-
cytosis, suggesting a possible aetiological relationship of
haemolysis with hypoxemia (Rackoff et al, 1993; Homi et al,
1997; Setty et al, 2003; Quinn & Ahmad, 2005; Kato et al,
2006). It has been proposed that this association might involve
haemolysis-associated ventilation-perfusion mismatch (Kato
et al, 2007a).
A developing paradigm of sickle cell disease manifestations
proposes two overlapping but distinctively characteristic
subphenotypes (Kato et al, 2007a). In the vasculopathy
subphenotype, complications such as stroke, pulmonary
hypertension, priapism and leg ulcers predominate and are
linked to the degree of haemolysis and associated vascular
dysfunction. In the vaso-occlusive subphenotype, markers of
increased blood viscosity predict risk for infarctive complica-
tions, such as frequent pain crises, acute chest syndrome and
avascular necrosis of bone. Steady state haemoglobin oxygen
desaturation is a risk factor for overt stroke (Quinn & Sargent,
2008) and for pulmonary hypertension (Pashankar et al, 2008;
Liem et al, 2009; Minniti et al, 2009) in sickle cell disease,
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Summary
Low steady state haemoglobin oxygen saturation in patients with sickle cell
anaemia has been associated with the degree of anaemia and haemolysis.
How much pulmonary dysfunction contributes to low saturation is not clear.
In a prospective study of children and adolescents with sickle cell disease aged
3–20 years at steady state and matched controls, 52% of 391 patients versus
24% of 63 controls had steady state oxygen saturation <99% (P < 0Æ0001),
9% of patients versus no controls had saturation <95% (P = 0Æ008) and 8%
of patients versus no controls had exercise-induced reduction in saturation
‡3%. Decreasing haemoglobin concentration (P £ 0Æ001) and increasing
haemolysis (P £ 0Æ003) but not pulmonary function tests were independent
predictors of both lower steady-state saturation and exercise-induced
reduction in saturation. Neither history of stroke nor history of acute chest
syndrome was significantly associated with lower steady-state oxygen
saturation or exercise-induced reduction in saturation. Tricuspid
regurgitation velocity was higher in patients with lower steady state
haemoglobin oxygen saturation (P = 0Æ003) and with greater decline in
oxygen saturation during the six-minute walk (P = 0Æ022). In conclusion,
lower haemoglobin oxygen saturation is independently associated with
increasing degrees of anaemia and haemolysis but not pulmonary function
abnormalities among children and adolescents with sickle cell disease.
Keywords: sickle cell disease, paediatric, oxygen saturation, six-minute walk,
pulmonary hypertension.
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two of the prominent manifestations of the haemolytic
subphenotype. Nocturnal oxygen desaturation is also a risk
factor for stroke, silent infarct or seizure (Kirkham et al, 2001).
On the other hand, reported associations of lower haemoglo-
bin oxygen saturation with increased episodes of pain (Har-
grave et al, 2003) and acute chest syndrome (Rackoff et al,
1993), manifestations of the vaso-occlusive subphenotype,
have not been confirmed in other studies (Quinn & Ahmad,
2005; Uong et al, 2006).
We recently reported the initial results of an ongoing
prospective, multicenter study of the prevalence and risk
factors for developing pulmonary hypertension in children
with sickle cell disease (PUSH Study) (Minniti et al, 2009).
Both haemolysis and oxygen desaturation were independently
associated with elevated tricuspid regurgitation velocity in this
study. Pulmonary function testing and a six-minute walk were
performed as a part of this study and pulse oximetry
measurements were made before and after the walk. We
hypothesized that lower oxygen saturations at steady state and
oxygen desaturation during the six-minute walk may reflect
pulmonary ventilation/perfusion mismatch related to the
vascular effects of accelerated haemolysis. We investigated
the relationship of oxygen saturation with medical history,
echocardiographic measurements, pulmonary function testing
and laboratory test results in this cohort.
Methods
Enrollment of participants
A total of 391 patients with sickle cell disease and 63 controls
were recruited at three tertiary medical centers: Children’s
National Medical Center and Howard University Hospital in
Washington DC, and University of Michigan, in Ann Arbor,
Michigan. Of these, 310 patients and 54 controls were
included in the initial report (Minniti et al, 2009). The
patients were of 3–20 years of age and had a diagnosis of
sickle cell disease confirmed with haemoglobin electro-
phoresis or high performance liquid chromatography. All
phenotypes were included, such as haemoglobins SS, SC,
Sb-thalassemia, SD, SO-Arab and others. The controls were
matched by age, sex and ethnicity to every sixth patient with
sickle cell disease. Children with sickle cell trait (n = 17) and
haemoglobin C trait (n = 5) also qualified as controls.
Patients were invited to participate on a consecutive basis,
as they presented for routine outpatient care; no attempt was
made to select them by known or perceived risk factors. To
ensure that patients were enrolled at steady state, at least
3 weeks had to have elapsed since hospitalization, emergency
department or clinic visit for acute chest syndrome, pain
crisis, infection or other sickle cell disease-related complica-
tion. Written informed consent was obtained for all partic-
ipants. Parents or legal guardians provided consent for
children ages 3–17 years. Participants from ages 18 to
20 years provided consent for themselves. Participants from
7 to 17 years provided additional written informed assent.
Patients receiving regular blood transfusions or hydroxycar-
bamide therapy were not excluded.
Clinical evaluation
Patients underwent medical history, physical examination and
measurement of oxygen saturation by pulse oximetry. Venous
blood was drawn for complete blood count, reticulocyte count
and serum chemistries.
Six-minute walk test
An unencouraged six-minute walk test was conducted in a
predetermined course, at least six feet wide, as per the
guidelines of the American Thoracic Society (ATS) (ATS
Committee on Proficiency Standards for Clinical Pulmonary
Function Laboratories 2002). This test measures the distance
that an individual can quickly walk on a flat, hard surface in
a period of 6 min. It is self-paced and rest is allowed during
the exercise. The distance walked was recorded in metres for
all subjects. Transcutaneous pulse oximetry haemoglobin
oxygen saturation measurements were obtained before, dur-
ing, and immediately after the six-minute walk test. Only
children older than 5 years of age were given this test, due to
the difficulty in obtaining reliable information from younger
participants.
Laboratory studies
Complete blood count and reticulocyte count were performed
by Beckman Coulter LH 750 Analyzer (Fullerton, CA, USA) at
Howard University and the University of Michigan, and by
Sysmex 2100QC (Sysmex America, Inc., Mundelein, IL, USA)
at the Children’s National Medical Center. Serum chemistries
were performed by Beckman Coulter Unicel DXC800 at
Howard University, by RXL 2 Max, Model 973626, (Dade-
Behring, Inc., Dover, DE, USA) at the Children’s National
Medical Center and by Siemens Advia 2400 (Deerfield, IL,
USA) at the University of Michigan. Pulse oximetry was
measured by Criticare Model 506 Series (Waukesha, WI, USA)
at Howard University, a Welch Allyn instrument (Beaverton,
OR, USA) or a SureSigns VS3 No. 3000 (Philips Medical
System, Andover, MA, USA) at the Children’s National
Medical Center and by a Masimo Rad 8 Signal Extraction
Pulse Oximeter at the University of Michigan. Reticulocyte
count and serum concentrations of lactate dehydrogenase,
aspartate aminotransferase and total bilirubin were prospec-
tively considered to be markers of haemolysis. Reference ranges
for Howard University, Children’s National Medical Center
and University of Michigan, respectively, were 25–75, 42–95
and 26–104 · 109/l for reticulocyte count; 0–250, 141–231
and 150–300 u/l for lactate dehydrogenase; 0–50, 10–36 and
5–60 u/l for aspartate aminotransferase; 3Æ4–20Æ5, <13Æ7 and
1Æ7–17Æ1 lmol/l for total bilirubin.
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Echocardiography
Transthoracic echocardiography was performed using the
Philips Sonos 5500/7500 or iE33 (Philips Medical Systems,
Best, Holland), Acuson Sequoa (Siemans Medical Systems,
Mountain View, CA, USA), or General Electric VIVID 7 or
VIVID I (General Electric, Milwaukee, WI, USA). All images
were recorded digitally and subsequently reviewed on an
offline digital work station. Cardiac images were obtained,
measurements were performed, and the studies were inter-
preted according to the guidelines of the American Society of
Echocardiography (Lai et al, 2006). Tricuspid regurgitation
was assessed in the parasternal long and short-axis, and apical
four-chamber views. Continuous-wave Doppler sampling was
used to determine the peak tricuspid regurgitation velocity,
which reflects systolic pulmonary artery pressure (Berger et al,
1985). Left ventricular diastolic function was assessed by
measuring the tissue Doppler E wave at the basilar segments of
the left ventricular free wall and the interventricular septum.
The mitral inflow E wave to tissue Doppler E wave (E/Etdi)
ratio reflects left atrial and left ventricular filling pressures
(Nagueh et al, 1997). Based on the systemic blood pressure-
and age-adjusted mean + 2 SDs in the controls of this study, a
peak tricuspid regurgitation velocity of ‡2Æ60 m/s and an
E/Etdi ‡ 8Æ9 was considered to be elevated.
Pulmonary function testing
Participants underwent spirometry and plethysmography,
according to the ATS standard protocols (Macintyre et al,
2005; Miller et al, 2005; Wanger et al, 2005). Pulmonary
function test results were expressed as a percentage of the
predicted value based on ethnic appropriate reference stan-
dards for spirometry (Hankinson et al, 1999). For plethys-
mography, results were expressed as a percentage of the
predicted race-adjusted reference standards (Pellegrino et al,
2005). The pulmonary function testing systems used were
VMAX 62J (Sensomedics, Vienna, Austria) at the University of
Michigan and Howard University and Elite DX (Medical
Graphics, St. Paul, MN, USA) at the Children’s National
Medical Center. The following parameters were included in the
analysis: forced vital capacity (FVC), forced expiratory volume
in 1 s (FEV1), FEV1/FVC, total lung capacity (TLC).
Statistical analysis
Analysis of variance was used to compare continuous variables
among groups of patients according to different baseline
haemoglobin oxygen saturations. The post hoc Bonferroni test
was used for pair-wise comparisons. The Student’s t-test or the
Kolmogorov–Smirnov nonparametric test (whichever appro-
priate) was used to compare continuous variables between
cases and controls, or two groups of patients according to six-
minute walk desaturation. For categorical variables we applied
the chi-square test. A stepwise linear regression model was
developed to identify independent predictors of steady-state
haemoglobin oxygen saturation. A stepwise logistic regression
model was developed to determine independent predictors of a
decline in oxygen saturation of three points or more during the
six-minute walk. P values <0Æ05 were considered significant.
Analyses were performed with stata 10 (StataCorp, College
Station, TX, USA).
Results
Steady-state haemoglobin oxygen saturation
The distribution of steady state haemoglobin oxygen satura-
tion in 391 children with sickle cell disease and 63 controls is
depicted in Fig 1. Two hundred and two (52%) of the patients
with sickle cell disease compared to 15 (24%) of the controls
had haemoglobin oxygen saturation <99% (P < 0Æ0001) while
9% of patients versus no controls had saturation <95%
(P = 0Æ008). Table I presents clinical findings stratified accord-
ing to those that might be predictors of steady state oxygen
saturation level and those that could be viewed as outcomes
associated with the degree of saturation. In bivariate analysis of
potential predictors of oxygen saturation, the following
showed significant correlations with lower saturation: male
sex, severe sickling phenotype, lower values for weight-for-age
z-score, haemoglobin concentration and TLC, and higher
values for four markers of haemolysis and a haemolytic
component derived from these markers. In bivariate analysis of
potential outcomes, lower oxygen saturation was associated
with higher values for tricuspid regurgitation velocity, which
reflects systolic pulmonary artery pressure, and with more
frequently having an exercise-induced decline in haemoglobin
oxygen saturation. Lower oxygen saturation was not associated
with increasing mitral valve E/Etdi, which reflects left ventric-
ular diastolic dysfunction, nor with shorter distance walked in
the six-minute walk or histories of acute chest syndrome,
frequent pain episodes or stroke.
Independent predictors of low baseline oxygen saturation
by multiple linear regression analysis
Both decreasing haemoglobin concentration (P = 0Æ001) and
increasing degree of haemolysis (P < 0Æ0001) were indepen-
dent predictors of lower steady state oxygen saturation among
the patients overall and age was also a predictor (P = 0Æ043)
(Table II). TLC did not have an independent association with
lower oxygen saturation. According to this model and with
other variables held constant, an increase in the haemolytic
index of 2 standard deviations (SD) was associated with a
decrease in the oxygen saturation of 1Æ4% (95% confidence
interval of 0Æ9–1Æ9%). Likewise, a reduction in the haemoglo-
bin concentration of 40 g/l is associated with a decrease in the
oxygen saturation of 1Æ0% (0Æ4–1Æ6%). FEV1, FVC, FEV1/FVC
ratio and TLC did not have independent associations with
oxygen saturation.
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Decline in haemoglobin oxygen desaturation during the
six-minute walk test (Table III)
Oxygen saturation was measured before and after the six-
minute walk test. A cut-off point of 3% or greater decline in
saturation during the walk was used to categorize the patients
into two groups. Among 323 patients with this available data,
27 (8%) had a reduction in oxygen saturation of three points
or more during the six-minute walk. None of the controls had
such a decline during the six-minute walk. In bivariate
analyses, younger age, severe sickling phenotype, lower values
for weight-for-age z-score, haemoglobin concentration and
baseline oxygen saturation and higher values for the haemo-
lytic component were predictors of exercise-induced decline in
oxygen saturation of three points or more. Histories of asthma
and obstructive sleep apnea did not predict desaturation
during exercise. Of potential outcomes, exercise-induced
decline in oxygen saturation had a significant association with
higher tricuspid regurgitation velocity but not with history of
acute chest syndrome or frequent severe pain episodes.
Interestingly, exercise-induced decline in oxygen saturation
appeared to be a better predictor of elevated tricuspid
regurgitation velocity than steady-state saturation: 29% of
patients with a decline in saturation of three points or more
had elevated tricuspid regurgitation velocity compared to 17%
of patients with steady state saturation <95%.
Independent predictors of exercise-induced decrease in
oxygen saturation by logistic regression analysis
By multivariate analysis, lower haemoglobin concentration
(P = 0Æ0003) and greater degree of haemolysis (P = 0Æ003) were
each independently associated with increased odds of exercise-
induced decrease in oxygen saturation (Table IV). Age, height,
sex, history of acute chest syndrome, baseline oxygen saturation
and histories of asthma or sleep apnea were not significantly
related to oxygen desaturation during the six-minute walk test.
Pulmonary function tests were not independent predictors of
exercise-induced decline in haemoglobin oxygen saturation.
Discussion
Both the degree of anaemia and the degree of haemolysis, as
indicated by a haemolytic component derived from four
markers, were found to be independent predictors of lower
steady state oxygen saturation and of oxygen-induced decline
in saturation in children and adolescents with sickle cell
disease. Increasing age was an additional independent predic-
tor of lower steady state oxygen saturation. Lower values for
FEV1, FVC, FEV1/FVC ratio and TLC were not independent
predictors of lower steady state oxygen saturation or exercise-
induced reduction in saturation. Neither lower steady state
oxygen saturation nor desaturation during exercise were
predictors of stroke, acute chest syndrome or severe pain
history.
Lower oxygen saturation in the setting of sickle cell disease
at steady state might be due to several factors including
intrinsic lung disease leading to reduced gas exchange and
alterations in the pulmonary vasculature or airways leading to
ventilation-perfusion mismatching. Further, altered affinity of
haemoglobin for oxygen and increased levels of methaemo-
globin or carboxyhaemoglobin may be other contributing
factors (Hurford & Kratz, 2004). Several factors could
contribute to decreased oxygen affinity, including the intrinsic
reduced affinity of haemoglobin S (Seakins et al, 1973; Ueda
et al, 1979), an increase in red blood cell 2,3-biphosphogly-
cerate related to the degree of anaemia (Milner, 1974) and/or
to haemoglobin S polymer formation in the red cells that
precedes overt sickling and haemolysis (Sunshine et al, 1982).
We did not have strong evidence of intrinsic lung disease in the
children with sickle cell disease in this study, and the lack of an
independent association of lower oxygen saturation with
pulmonary function test abnormalities or histories of asthma,
acute chest syndrome, and sleep apnea is also against intrinsic
lung disease as a major contributing factor. On the other hand,
the independent association of lower haemoglobin with lower
oxygen saturation might plausibly be related to increased levels
of red cell 2,3-biphosphoglycerate and the independent
association with haemolysis to increased haemoglobin S
polymer formation. In addition, our finding of an association
of greater haemolysis with lower oxygen saturation in all of the
statistical analyses that we performed was consistent with the
possibility that haemolysis induces changes in the pulmonary
vasculature and airways that limit the acquisition of oxygen by
haemoglobin in sickle cell disease, thus supporting ventilation-
perfusion mismatching as a consequence of haemolysis-
induced pulmonary vasculopathy (Kato et al, 2007a).
This study is limited by the fact that arterial blood gases
were not performed to confirm pO2 and oxygen saturation,
Fig 1. Steady-state haemoglobin oxygen saturation in patients with
sickle cell disease and controls. The steady state distribution of hae-
moglobin oxygen saturation in 391 children with sickle cell disease and
63 controls is depicted. Two hundred and two (52%) of the patients
with sickle cell disease compared to 15 (24%) of the controls had
haemoglobin oxygen saturation <99% while 9% of patients versus no
controls had saturation <95% (P = 0Æ008).
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and some evidence suggests that pulse oximetry is not reliable
in sickle cell disease (Blaisdell et al, 2000). However, a number
of other studies have indicated that pulse oximetry is reliable
for diagnosing hypoxia during steady state conditions and with
acute complications in sickle cell disease patients (Rackoff
et al, 1993; Kress et al, 1999; Ortiz et al, 1999). Another
limitation of our study is that it is cross-sectional rather than
longitudinal. Nevertheless, the findings presented here con-
firm, in one prospective study, the observations of a number of
other investigators. In particular, other investigations have also
shown relationships of lower oxygen saturation in sickle cell
disease patients with severe anaemia, more severe sickling
phenotype (haemoglobins SS and Sb0 thalassemia) (Rackoff
et al, 1993; Homi et al, 1997) and/or with haemolysis
(Setty et al, 2003; Quinn & Ahmad, 2005; Kato et al, 2006;
Pashankar et al, 2008; Quinn & Sargent, 2008; Liem et al,
2009). For example, the Dallas Newborn Cohort Study of 585
patients showed independent associations of both the haemo-
lytic marker, reticulocyte count, and low haemoglobin
concentration with lower oxygen saturation, with the haemo-
lytic marker explaining more of the oxygen saturation than the
haemoglobin concentration (Quinn & Ahmad, 2005); our
study was able to duplicate these observations. Our findings
point to a potential interrelationship between haemolysis and
hypoxia in predicting certain complications of sickle cell
disease. An increase in the haemolytic index of 2 SD was
Table I. Clinical data by haemoglobin oxygen saturation group. Results in median and interquartile range unless otherwise indicated.
N O2 sat. > 98% N O2 sat. 95–98% N O2 sat. < 95% P
Potential predictors of O2 saturation
Age (years) 189 12 (7–16) 168 13 (8–16) 34 12 (8–16) 0Æ7
Female sex* 189 104 (55%) 168 69 (41%) 34 17 (50%) 0Æ030
Severe sickling phenotype
(Hb SS, Sb0 thal or SDLA)*
185 119 (64%) 167 137 (82%) 34 34 (100%) <0Æ0001
Regular transfusion programme* 183 25 (14%) 162 24 (15%) 32 4 (13%) 0Æ9
Weight for age Z score 175 0Æ2 ()0Æ5–1Æ0) 161 0 ()0Æ8–0Æ8) 34 )0Æ5 ()1Æ1–0Æ1) 0Æ002
Hydroxycarbamide therapy* 185 68 (37%) 163 70 (43%) 32 6 (19%) 0Æ033
History of asthma* 186 43 (23%) 163 45 (28%) 31 9 (29%) 0Æ6
History of obstructive sleep apnea* 186 19 (10%) 163 15 (9%) 32 6 (19%) 0Æ3
Haemoglobin (g/l) 184 98 (88–111) 159 88 (79–99) 33 78 (69–85) <0Æ0001
Lactate dehydrogenase (u/l) 168 334 (250–461) 150 411 (300–549) 32 552 (458–694) <0Æ0001
Reticulocytes (· 109/l) 177 173 (127–255) 159 244 (168–351) 33 298 (248–435) <0Æ0001
Aspartate amino-transferase (u/l) 183 35 (27–50) 161 42 (31–53) 34 53 (46–66) <0Æ0001
Total bilirubin (lmol/l) 184 29 (19–46) 160 43 (29–68) 34 56 (39–82) <0Æ0001
Haemolytic component 160 )0Æ6 ()1Æ6–0Æ8) 145 0Æ4 ()0Æ7–1Æ3) 31 1Æ3 (0Æ5–2Æ4) <0Æ0001
FEV1/FVC 64 84 (81–89) 55 86 (80–89) 18 84 (79–87) 0Æ5
TLC 47 104 (94–114) 36 103 (89–111) 14 88 (84–92) 0Æ006
DLCO 47 94 (85–105) 38 102 (88–113) 13 93 (91–98) 0Æ1
Potential outcomes associated with level of O2 saturation
TRV (m/s) 167 2Æ3 (2Æ1–2Æ4) 149 2Æ4 (2Æ2–2Æ5) 30 2Æ4 (2Æ3–2Æ5) 0Æ003
TRV ‡ 2Æ6* 167 10 (6%) 149 23 (15%) 30 5 (17%) 0Æ016
Mitral valve E/Etdi 173 6Æ3 (5Æ5–7Æ5) 157 6Æ4 (5Æ6–7Æ3) 33 6Æ6 (5Æ7–8Æ2) 0Æ3
Mitral valve E/Etdi ‡ 8Æ9* 173 16 (9%) 157 9 (6%) 33 4 (12%) 0Æ3
Six-minute walk distance (m) 146 451 (402–508) 141 433 (388–501) 28 478 (398–520) 0Æ4§
Decline in oxygen saturation
of ‡3% during walk
146 7 (5%) 140 13 (9%) 27 7 (26%) 0Æ001
History of acute chest syndrome* 186 51 (27%) 163 53 (32%) 32 8 (25%) 0Æ5
History of ‡2 severe pain
episodes past year*
189 55 (29%) 168 55 (33%) 34 7 (21%) 0Æ3
History >20 units of
blood transfused*
185 25 (14%) 160 19 (12%) 32 6 (19%) 0Æ6
History of stroke* 185 18 (10%) 163 17 (10%) 31 6 (19%) 0Æ3
History of priapism* 81 18 (22%) 92 18 (20%) 15 2 (13%) 0Æ7
FEV, forced expiratory volume in 1 s; FVC, forced vital capacity; TLC, total lung capacity; DLCO, Diffusion capacity for carbon monoxide; TRV,
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associated with a 1Æ4% decrease in the oxygen saturation
within our cohort. Increased haemolysis may contribute to the
development of hypoxia by inducing changes in the pulmonary
vessels and airways that lead to ventilation-perfusion mis-
matching. In turn, hypoxia may contribute to the development
of haemolytic complications, such as pulmonary hypertension.
Patients in the present study with the lower steady state
oxygen saturation or ‡3% reduction in oxygen saturation with
exercise had similar statistically significant clinical and labo-
ratory correlates (i.e. markers of haemolysis, lower haemoglo-
bin concentration and higher tricuspid regurgitation velocity).
Surrogate markers for diagnosing pulmonary hypertension and
predicting its severity in sickle cell disease adult patients are
being developed (Machado et al, 2006). However, there are no
models for predicting the early development of pulmonary
hypertension in children (Kato et al, 2007b). Inferring from
the results of our study, lower steady state oxygen saturation
and an acute decline of 3% in oxygen saturation from baseline
Table II. Independent predictors of steady state haemoglobin oxygen







)0Æ71 )0Æ97 to )0Æ45 <0Æ0001
Haemoglobin
(10 g/l decrease)
)0Æ25 )0Æ11 to )0Æ40 0Æ001
Age (1 year increase) )0Æ04 )0Æ08 to )0Æ001 0Æ043
FEV, forced expiratory volume in 1 s; FVC, forced vital capacity; TLC,
total lung capacity; DLCO, diffusion capacity for carbon monoxide;
SD, standard deviation.
*r-square = 0Æ25 for model. The following variables were entered into
the model initially: sex, age, hydroxycarbamide therapy, history of
asthma, history of sleep apnea, weight for age z-score, haemoglobin,
haemolytic component, TLC, FEV1/FVC and DLCO.
Table III. Clinical and laboratory results by six-minute walk-induced decline in oxygen saturation groups among participants with sickle cell disease
(results in median and interquartile range unless otherwise indicated).
N O2 saturation reduction < 3 N O2 saturation reduction ‡ 3 P value
Potential predictors of exercise-induced decline in oxygen saturation
Age (year) 296 13 (9–17) 27 11 (9–14) 0Æ030
Female sex* 296 145 (49%) 27 9 (33%) 0Æ12
Severe sickling phenotype
(Hb SS, Sb0 thal or SDLA)*
292 214 (73%) 27 25 (93%) 0Æ027
Weight for age Z score 271 0Æ1 ()0Æ7–0Æ8) 26 )0Æ4 ()1Æ1–0Æ2) 0Æ003
Regular transfusion programme* 287 38 (13%) 27 6 (22%) 0Æ2
Hydroxycarbamide therapy* 291 123 (42%) 27 8 (27%) 0Æ2
History of asthma* 291 72 (25%) 27 9 (33%) 0Æ3
History of obstructive sleep apnea* 292 28 (10%) 27 5 (19%) 0Æ15
History of >20 units of blood transfused* 289 42 (15%) 27 1 (4%) 0Æ12
Baseline oxygen saturation (%) 296 99 (97–100) 27 97 (96–99) 0Æ010
Haemoglobin (g/l) 285 94 (83–108) 26 75 (69–83) <0Æ0001
Haemolytic component 261 )0Æ1 ()1Æ2–0Æ9) 24 1Æ1 (0Æ3–2Æ4) <0Æ0001
FEV1/FVC 112 84 (80–89) 17 85 (79–87) 0Æ4
TLC 80 103 (91–112) 12 92 (81–107) 0Æ2
DLCO 79 97 (86–109) 14 103 (92–113) 0Æ4
Potential outcomes associated with exercise-induced decline in oxygen saturation
TRV (m/s) 257 2Æ3 (2Æ1–2Æ5) 24 2Æ4 (2Æ2–2Æ6) 0Æ022
TRV ‡ 2Æ6* 257 26 (10Æ1%) 24 7 (29Æ2%) 0Æ006
Mitral valve E/Etdi 267 6Æ3 (5Æ5–7Æ4) 25 6Æ9 (6Æ0–7Æ4) 0Æ1
Mitral valve E/Etdi ‡8Æ9* 267 21 (7Æ9%) 25 3 (12Æ0%) 0Æ5
Six-minute walk distance (m) 296 443 (402–504) 27 431 (357–515) 0Æ8§
History of acute chest syndrome * 292 85 (29%) 27 9 (33%) 0Æ6
History of stroke* 290 30 (10%) 27 2 (7%) 0Æ6
History of priapism* 145 26 (18%) 18 6 (33%) 0Æ12
FEV, forced expiratory volume in 1 s; FVC, forced vital capacity; TLC, total lung capacity; DLCO, diffusion capacity for carbon monoxide; TRV,
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during the six-minute walk test may serve as early markers for
future development of pulmonary hypertension in children.
Therefore, future studies are warranted to longitudinally follow
children and adolescents with sickle cell disease.
In conclusion, our findings provide evidence that low
haemoglobin oxygen saturation should be considered as a
potential feature of the haemolytic vasculopathy sub-pheno-
type of sickle cell disease. Haemolysis-related pulmonary
vascular dysfunction may underlie both oxygen desaturation
through ventilation/perfusion mismatch and shunting as well
as pulmonary hypertension.
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